Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

GUJARAT TERCE LABORATORIES LTD

Healthcare › Pharmaceuticals & Biotechnology

₹42.80

at close · 28 Oct 2026

▲ 2.80 (+7.00%)

Get alerts

Latest filings

Fri, 9 OctRoutine filing of dematerialisation certificate for Jul to Sep 2026 quarter · Compliance
Sun, 27 SeptTrading window closed from 1 Oct 2026 ahead of Q2 results · Compliance
Fri, 21 AugAGM 2026: All 4 resolutions passed with 100 percent approval · Board & Shareholder Meetings

All filings ↓

Ask Nexa about GUJARAT TERCE LABORATORIES LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE.

Market Cap

₹33 Cr

P / E (TTM)

—

EV / EBITDA

—

Div Yield

—

Growth

—·

Revenue 5y CAGR

PAT — · EBITDA —

Quality

—·

ROCE

ROE — · margin —

Leverage

—·

Debt / Equity

Net debt ₹2.09 Cr

Moves on a normal day

2.41%·

Median daily move

Last 266 sessions · the yardstick for filing-day moves

Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures

P/E (TTM)#126/158

P/B#80/163

ROCE#137/183

ROE#123/166

Debt / Equity#93/166

EBITDA margin#142/165

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers — not investment advice

Not enough history to assess.

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Governance

Is the board independent, clean and well-run?

Compliance

Did a company secretary sign off that it's clean?

Audit Report

What the auditor actually said — opinion, key audit matters, CARO clauses.

Earnings Call

What management said — and how it landed.

Investor Presentation

An AI read of the latest deck — verdict, KPIs, key slides and what it promised.

Events

Board meetings and results dates, upcoming and recent.

Reactions

How does the stock move after this company files?

Filings

The full disclosure feed.

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from GUJARAT TERCE LABORATORIES LTD's filed financials and exchange disclosures

What does GUJARAT TERCE LABORATORIES LTD do?

GUJARAT TERCE LABORATORIES LTD is a Pharmaceuticals & Biotechnology company listed on BSE.

Is GUJARAT TERCE LABORATORIES LTD debt-free?

No. It reported borrowings of ₹2.21 Cr on its 30 Sept 2019 balance sheet, or net debt of ₹2.09 Cr after cash.

How much does the GUJARAT TERCE LABORATORIES LTD share price move in a day?

On a typical session GUJARAT TERCE LABORATORIES LTD moves 2.41% — that is the median absolute close-to-close move across its last 266 trading days. MarketPing measures each filing's price reaction against it.

Where can I track GUJARAT TERCE LABORATORIES LTD's announcements?

Every NSE and BSE filing by GUJARAT TERCE LABORATORIES LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.